Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-Analysis
- PMID: 38874580
- DOI: 10.1056/EVIDoa2400134
Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding - An Updated Meta-Analysis
Abstract
Background: The goal of this systematic review was to examine the efficacy and safety of proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients.
Methods: We included randomized trials comparing proton-pump inhibitors versus placebo or no prophylaxis in critically ill adults, performed meta-analyses, and assessed certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluations approach. To explore the effect of proton-pump inhibitors on mortality based on disease severity, a subgroup analysis was conducted combining within-trial subgroup data from the two largest trials and assessed credibility using the Instrument for Assessing the Credibility of Effect Modification Analyses.
Results: Twelve trials that enrolled 9533 patients were included. Proton-pump inhibitors were associated with a reduced incidence of clinically important upper gastrointestinal bleeding (relative risk [RR], 0.51 [95% confidence interval (CI), 0.34 to 0.76]; high certainty evidence). Proton-pump inhibitors may have little or no effect on mortality (RR, 0.99 [95% CI, 0.93 to 1.05]; low certainty). Within-trial subgroup analysis with intermediate credibility suggested that the effect of proton-pump inhibitors on mortality may differ based on disease severity. Subgroup results raise the possibility that proton-pump inhibitors may decrease 90-day mortality in less severely ill patients (RR, 0.89; 95% CI, 0.80 to 0.98) and may increase mortality in more severely ill patients (RR, 1.08; 95% CI, 0.96 to 1.20]. Proton-pump inhibitors may have no effect on pneumonia and little or no effect on Clostridioides difficile infection (low certainty).
Conclusions: High certainty evidence supports the association of proton-pump inhibitors with decreased upper gastrointestinal bleeding. Proton-pump inhibitors may have little or no effect on mortality, although a decrease in mortality in less severely ill patients and an increase in mortality in more severely ill patients remain possible. (PROSPERO number CRD42023461695.).
Similar articles
-
Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD008687. doi: 10.1002/14651858.CD008687.pub2. Cochrane Database Syst Rev. 2018. PMID: 29862492 Free PMC article. Review.
-
Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials.Intensive Care Med. 2020 Nov;46(11):1987-2000. doi: 10.1007/s00134-020-06209-w. Epub 2020 Aug 24. Intensive Care Med. 2020. PMID: 32833040
-
Proton pump inhibitors for gastrointestinal bleeding prophylaxis in critically ill patients: A systematic review protocol.Acta Anaesthesiol Scand. 2024 Aug;68(7):983-988. doi: 10.1111/aas.14426. Epub 2024 Apr 5. Acta Anaesthesiol Scand. 2024. PMID: 38581102 Review.
-
Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.Crit Care Med. 2013 Mar;41(3):693-705. doi: 10.1097/CCM.0b013e3182758734. Crit Care Med. 2013. PMID: 23318494 Review.
-
Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.BMC Gastroenterol. 2019 Nov 21;19(1):193. doi: 10.1186/s12876-019-1105-y. BMC Gastroenterol. 2019. PMID: 31752703 Free PMC article. Review.
Cited by
-
Utilizing point-of-care lactate testing for rapid prediction of clinical outcomes in patients with acute gastrointestinal bleeding in the emergency department.Heliyon. 2024 Sep 19;10(18):e38184. doi: 10.1016/j.heliyon.2024.e38184. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39381254 Free PMC article.
-
[Stress ulcer prophylaxis with proton pump inhibitors in intensive care medicine].Med Klin Intensivmed Notfmed. 2024 Oct;119(7):598-599. doi: 10.1007/s00063-024-01172-6. Epub 2024 Aug 9. Med Klin Intensivmed Notfmed. 2024. PMID: 39120611 German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical